SEQIRUS INC - THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED
Key Details
Description
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED
Context & Analysis
On Jan 22, 2026, Department of Health and Human Services obligated $14,834,884.92 to SEQIRUS INC for the purpose of this requirement is to provide medical countermeasures (mcms), such as vaccines and adjuvants, for pandemic preparedness and response or as required in response to a hhs designated. The award is classified under NAICS 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in HOLLY SPRINGS, NC. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325414 — related awards are listed below.
Market context
- Recompete outlook
- Ended May 21, 2026 (5 months ago). Recompete signal as of Oct 21, 2026: 48/100, combining time to the end date, the incumbent's history with this agency, whether the award was competed, and its size.
- Competition
- Competed. 48% of 44 awards in this market (Department of Health and Human Services awards in NAICS 325414 over the last 3 years) were competed; median 2 offers.
- Award size
- At $14.8M, this award is above the median of the 39 priced Department of Health and Human Services awards in NAICS 325414 over the last 3 years (median $270K).
- Incumbent at this agency
- SEQIRUS INC has 4 other awards from Department of Health and Human Services, totalling $1.4B, 2025–2026.
- Largest vendors in this market
By obligations, Department of Health and Human Services awards in NAICS 325414 over the last 3 years.
- ADVANCED TECHNOLOGY INTERNATIONAL — 10 awards, $917.0M
- SANOFI VACCINES US INC. — 3 awards, $718.6M
- MILTENYI BIOTEC, INC. — 2 awards, $5.1M
- HOLOGIC SALES AND SERVICE, LLC — 2 awards, $1.6M
- VBI VACCINES (DELAWARE) INC. — 1 award, $152K
Computed from USAspending award data on Oct 21, 2026.
Contractor Information
Similar Awards
DEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES
SANOFI VACCINES US INC.
$612.2M
OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
ADVANCED TECHNOLOGY INTERNATIONAL
$304.0M
EXPANSION OF PRODUCTION CAPACITY OF MAN-MADE FABRIC FOR MANUFACTURING DISPOSABLE MEDICAL GOWNS
ADVANCED TECHNOLOGY INTERNATIONAL
$248.5M
OTHER TRANSACTION: PROCUREMENT AND SUSTAINMENT OF N95 MASK MANUFACTURING CAPACITY UNDER THE BIOMAP-CONSORTIUM.
ADVANCED TECHNOLOGY INTERNATIONAL
$141.3M
EXPANSION OF DOMESTIC MANUFACTURING CAPACITY FOR NITRILE GLOVES
ADVANCED TECHNOLOGY INTERNATIONAL
$61.0M
Stay Updated
Get notified about new opportunities matching your interests.